MktsMarkets

Biohaven Ltd.
NYSE: BHVNKey statistics
BHVN News
Stories mentioning BHVN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 103,827 | 121,945 | 141,169 | 184,367 | 187,584 | 167,473 | 157,607 | 314,819 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (130,428) | (142,734) | (169,382) | (211,701) | (221,561) | (189,931) | (178,168) | (333,772) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (130,260) | (145,204) | (173,222) | (197,886) | (221,068) | (186,795) | (160,363) | (319,594) |
| Tax Provision | 272.00 | 351.00 | 221.00 | 261.00 | 609.00 | 48.00 | (59.00) | 177.00 |
| Net Income (Loss) | (130,532) | (145,555) | (173,443) | (198,147) | (221,677) | (186,843) | (160,304) | (319,771) |
| Earnings Per Share (Basic) | (0.88) | (1.35) | (1.64) | (1.94) | (2.17) | (2.05) | (1.70) | (3.64) |
| Earnings Per Share (Diluted) | (0.88) | (1.35) | (1.64) | (1.94) | (2.17) | (2.05) | (1.70) | (3.64) |
| Weighted Average Shares Outstanding (Basic) | 147,615 | 107,625 | 105,815 | 102,373 | 101,943 | 91,234 | 94,372 | 87,766 |
| Weighted Average Shares Outstanding (Diluted) | 147,615 | 107,625 | 105,815 | 102,373 | 101,943 | 91,234 | 94,372 | 87,766 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BHVN
Biohaven Ltd. (NYSE: BHVN) is a stock listed on the New York Stock Exchange under the ticker symbol BHVN. It last traded at $14.48 (Nov 6, 2026, 4:00 PM ET), up 4.2% on the day. That gives Biohaven a market capitalisation of $2.2B.
Over the past 52 weeks BHVN has traded between $7.48 and $18.24.
For the quarter ended Mar 31, 2026 it reported a net loss of $130.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$130.5M |
| Dec 31, 2025 | — | -$145.6M |
| Sep 30, 2025 | — | -$173.4M |
| Jun 30, 2025 | — | -$198.1M |
From Biohaven’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…